dc.creator |
Russell, Mark |
|
dc.creator |
Taniguchi, K |
|
dc.creator |
Richardson, Sarah |
|
dc.creator |
Morgan, Noel |
|
dc.date |
2016-03-21T13:16:02Z |
|
dc.date |
2016-03-21T13:16:02Z |
|
dc.date |
2016-03 |
|
dc.date.accessioned |
2023-02-17T19:48:02Z |
|
dc.date.available |
2023-02-17T19:48:02Z |
|
dc.identifier |
STAT6, a novel regulator of beta cell viability, is reduced in islets of patients with recent-onset Type 1 diabetes. in: Basic and clinical science posters: beta cells, islets and stem cells 2016, 33:37 Diabetic Medicine |
|
dc.identifier |
07423071 |
|
dc.identifier |
10.1111/dme.2_13048 |
|
dc.identifier |
http://hdl.handle.net/11287/602312 |
|
dc.identifier |
Diabetic Medicine |
|
dc.identifier.uri |
http://localhost:8080/xmlui/handle/CUHPOERS/241999 |
|
dc.language |
en |
|
dc.publisher |
Wiley |
|
dc.relation |
http://doi.wiley.com/10.1111/dme.2_13048 |
|
dc.rights |
Archived with thanks to Diabetic Medicine |
|
dc.subject |
Wessex Classification Subject Headings::Endocrinology::Diabetes |
|
dc.title |
STAT6, a novel regulator of beta cell viability, is reduced in islets of patients with recent-onset Type 1 diabetes. |
|
dc.title |
Basic and clinical science posters: beta cells, islets and stem cells |
|
dc.type |
Poster |
|
dc.type |
Published |
|